RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: metabolic dysfunction-associated steatohepatitis
Accession: DOID:0080547
browse the term
Definition: A metabolic dysfunction-associated steatotic liver disease characterized by the presence of inflammation with hepatocyte injury such as ballooning, with or without fibrosis. (DO)
Synonyms: exact_synonym: MASH; NASH; non-alcoholic steatohepatitis; nonalcoholic steatohepatitides; nonalcoholic steatohepatitis
xref: EFO:1001249
G
Abca1
ATP binding cassette subfamily A member 1
treatment
ISO
RGD
PMID:29505790
RGD:19165131
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Acaca
acetyl-CoA carboxylase alpha
treatment
IEP
RGD
PMID:28458350
RGD:401799674
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acer3
alkaline ceramidase 3
disease_progression treatment
ISO
mRNA:increased expression:liver
RGD
PMID:31949129 PMID:31949129 PMID:31949129
RGD:35673324 , RGD:35673324 , RGD:35673324
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
G
Acta2
actin alpha 2, smooth muscle
ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adipor2
adiponectin receptor 2
susceptibility treatment
IEP ISO
mRNA:decreased expression:liver (rat) associated with obesity;protein:decreased expression:liver (mouse)
RGD
PMID:20606728 PMID:19763702 PMID:18666257 PMID:20965162 PMID:30131158
RGD:21076282 , RGD:25330094 , RGD:25330095 , RGD:25440494 , RGD:25824942
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adra2a
adrenoceptor alpha 2A
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Apoa1
apolipoprotein A1
treatment
ISO IEP
human gene in mouse model mRNA, protein: increased expression:liver, serum (rat)
RGD
PMID:24793484 PMID:30187493
RGD:21408551 , RGD:25671434
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
treatment
IEP
associated with type 2 diabetes mellitus;
RGD
PMID:29608898
RGD:153352320
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
G
Birc3
baculoviral IAP repeat-containing 3
ISO
protein:increased expression:liver (human)
RGD
PMID:29307797
RGD:153297819
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Ccl2
C-C motif chemokine ligand 2
susceptibility
ISO IEP
RNA:increased expression:liver: mRNA:increased expression:liver mRNA:increased expression:liver (rat)
RGD
PMID:24429361 PMID:30369082 PMID:20606728
RGD:14975280 , RGD:14995462 , RGD:21076282
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:serum:
RGD
PMID:27639593
RGD:14995335
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cldn1
claudin 1
IEP
mRNA:increased expression:distal colon (rat)
RGD
PMID:31189495
RGD:26884351
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Col1a1
collagen type I alpha 1 chain
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Cpt1a
carnitine palmitoyltransferase 1A
treatment
IEP
RGD
PMID:28458350
RGD:401799674
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Cxcl10
C-X-C motif chemokine ligand 10
severity
ISO
mRNA,protein:increased expression:liver,serum
RGD
PMID:25048951 PMID:25048951
RGD:27095890 , RGD:27095890
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:28774887
RGD:15045601
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
treatment
ISO IEP
mRNA:increased expression:liver (human) mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:28774887 PMID:30038487
RGD:15045601 , RGD:15092090
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Gpbar1
G protein-coupled bile acid receptor 1
treatment
IEP
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487
RGD:15092090
NCBI chr 9:75,860,758...75,863,260
Ensembl chr 9:75,860,677...75,863,168
G
Htr2b
5-hydroxytryptamine receptor 2B
ISO
associated with morbid obesity;mRNA:decreased expression:liver
RGD
PMID:33081272
RGD:401900305
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ameliorates
ISO
RGD
PMID:28415887
RGD:14985253
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ifng
interferon gamma
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
ISO
DNA:SNP:promoter:-1082A>G (rs1800896) (human)
RGD
PMID:28852433
RGD:14975143
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
ameliorates
ISO
DNA:SNP:promoter:-174���G/C (human)
RGD
PMID:28852433 PMID:28100771
RGD:14975143 , RGD:127285675
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf5
interferon regulatory factor 5
ISO
mRNA:increased expression:liver
RGD
PMID:27942586
RGD:40924562
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Jak2
Janus kinase 2
ameliorates
ISO
RGD
PMID:28100771
RGD:127285675
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Krt18
keratin 18
severity
ISO IEP ISS
protein:increased degradation:plasma (human) protein:increased degradation:serum (human) associated with morbid obesity;protein:increased degradation: plasma(human) protein:increased expression:serum (human) protein:altered degradation:liver, serum (rat)
MouseDO RGD
PMID:19585618 PMID:24630506 PMID:19333204 PMID:18995215 PMID:21993925 PMID:24071521 More...
RGD:18337489 , RGD:18337490 , RGD:18337493 , RGD:18337495 , RGD:18337499 , RGD:27226810
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Lepr
leptin receptor
susceptibility
ISO
DNA:SNPs: :rs1137100,rs1137101(human)
RGD
PMID:23278404
RGD:14696696
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Mc4r
melanocortin 4 receptor
ISS
MouseDO
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
ISO
RGD
PMID:32015322
RGD:151356909
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mir21
microRNA 21
ameliorates
ISO
RNA:increased expression:liver
RGD
PMID:26338827 PMID:26338827
RGD:41404659 , RGD:41404659
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir221
microRNA 221
treatment disease_progression
ISO
RGD
PMID:30316865 PMID:22267590
RGD:18337274 , RGD:151709001
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
G
Mir222
microRNA 222
disease_progression
ISO
RGD
PMID:22267590
RGD:151709001
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
G
Mir223
microRNA 223
treatment
ISO
RNA:increased expression:liver:
RGD
PMID:31585800 PMID:30964207 PMID:30964207
RGD:21408547 , RGD:21408549 , RGD:21408549
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mlxipl
MLX interacting protein-like
treatment
IEP
RGD
PMID:28458350
RGD:401799674
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
G
Myd88
MYD88, innate immune signal transduction adaptor
treatment
ISO
RGD
PMID:25790822
RGD:150519907
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:25385666
RGD:21201312
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
treatment
IEP
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487
RGD:15092090
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nox4
NADPH oxidase 4
susceptibility
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:20606728
RGD:21076282
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment
ISO IEP
mRNA:increased expression:liver (human) mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:28774887 PMID:30038487
RGD:15045601 , RGD:15092090
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Pck1
phosphoenolpyruvate carboxykinase 1
treatment
IEP
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487
RGD:15092090
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Ripk3
receptor-interacting serine-threonine kinase 3
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21425308
RGD:127229938
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Scd
stearoyl-CoA desaturase
treatment
IEP
RGD
PMID:28458350
RGD:401799674
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Serpinf1
serpin family F member 1
treatment
ISO
human gene in a mouse model protein:increased expression:serum (human)
RGD
PMID:28365916 PMID:26121037
RGD:27226700 , RGD:27226705
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Smad4
SMAD family member 4
ISO
protein:increased expression:liver:
RGD
PMID:29696816 PMID:29696816
RGD:18937002 , RGD:18937002
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Sod1
superoxide dismutase 1
susceptibility
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:20606728
RGD:21076282
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
susceptibility
IEP ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:20606728 PMID:24649902
RGD:21076282 , RGD:26923960
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
IEP
mRNA, protein:altered expression:liver (rat) treatment with INT-767
RGD
PMID:30038487 PMID:28458350
RGD:15092090 , RGD:401799674
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tlr2
toll-like receptor 2
ISO
RGD
PMID:29482933
RGD:15090806
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr9
toll-like receptor 9
disease_progression
ISO
mRNA, protein:increased expression:serum, liver (mouse)
RGD
PMID:24650018
RGD:18337469
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
susceptibility
IEP ISO
mRNA:increased expression:liver (rat) mRNA:increased expression:liver (mouse)
RGD
PMID:20606728 PMID:28100771
RGD:21076282 , RGD:127285675
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Txnip
thioredoxin interacting protein
ISO
RGD
PMID:29482933
RGD:15090806
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Ubd
ubiquitin D
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all